Ghalandari, N. https://orcid.org/0000-0002-7130-2749
Dolhain, R. J. E. M.
Hazes, J. M. W.
van Puijenbroek, E. P.
Kapur, M.
Crijns, H. J. M. J.
Funding for this research was provided by:
College ter Beoordeling van Geneesmiddelen
Article History
First Online: 27 August 2020
Declarations
:
: This study was part of N. Ghalandari’s PhD project. The entire PhD project is funded by Dutch Medicines Evaluation Board (CBG-MEB).
: Dr. R.J.E.M. Dolhain received an unrestricted grant from UCB Pharma B.V. and the Dutch Arthritis Association. The other authors have no conflicts to declare.
: All data generated or analyzed during this study are included in this published article (and its supplementary information files). All included articles are listed as references.
: All articles were extracted from the following databases: Embase.com, Medline Ovid, Web of science, Cochrane CENTRAL, and Google scholar.
: NG: conceptualization, methodology, investigation, resources, data curation, writing the original draft, visualization. RJEMD: conceptualization, validation, writing—review and editing, supervision. JMWH: calidation, writing—review and editing, supervision. EPvanP: validation, writing—review and editing, supervision. MK: resources, data curation, visualization. HJMJC: methodology, investigation, resources, data curation, validation, writing—review and editing, project administration.